|
75
|
226
|
7vueA |
Structural insight of the molecular mechanism of cilofexor bound to fxr |
|
80
|
229
|
7trbA |
Crystal structure of farnesoid x-activated receptor complexed with compound-32 aka (1s,3s)-n-({4-[5-(2-fluoropr opan-2-yl)-1,2,4-oxadiazol-3-yl]bicyclo[2.2.2]octan-1-yl}m ethyl)-3-hydroxy-n-[4'-(2-hydroxypropan-2-yl)-[1,1'-biphen yl]-3-yl]-3-(trifluoromethyl)cyclobutane-1-carboxamide |
|
3
|
11
|
7trbC |
Crystal structure of farnesoid x-activated receptor complexed with compound-32 aka (1s,3s)-n-({4-[5-(2-fluoropr opan-2-yl)-1,2,4-oxadiazol-3-yl]bicyclo[2.2.2]octan-1-yl}m ethyl)-3-hydroxy-n-[4'-(2-hydroxypropan-2-yl)-[1,1'-biphen yl]-3-yl]-3-(trifluoromethyl)cyclobutane-1-carboxamide |
|
2
|
11
|
7d42B |
Structural basis of tropifexor as a potent and selective agonist for farnesoid x receptor |
|
75
|
226
|
7d42A |
Structural basis of tropifexor as a potent and selective agonist for farnesoid x receptor |
|
3
|
12
|
6itmB |
Crystal structure of fxr in complex with agonist xj034 |
|
91
|
228
|
6itmA |
Crystal structure of fxr in complex with agonist xj034 |
|
3
|
10
|
5y1jU |
Crystal structure of human fxr in complex with a functional drug ligand |
|
91
|
228
|
5y1jA |
Crystal structure of human fxr in complex with a functional drug ligand |
|
3
|
11
|
6a5xB |
Fxr-lbd with hnc180 and src1 |
|
82
|
230
|
6a5yD |
Crystal structure of human fxr/rxr-lbd heterodimer bound to hnc143 and 9cra and src1 |
|
81
|
228
|
6a5zA |
Crystal structure of human fxr/rxr-lbd heterodimer bound to hnc180 and 9cra and src1 |
|
2
|
15
|
6a5zE |
Crystal structure of human fxr/rxr-lbd heterodimer bound to hnc180 and 9cra and src1 |
|
85
|
228
|
6a5wA |
Fxr-lbd with hnc143 and src1 |
|
79
|
229
|
6a5zD |
Crystal structure of human fxr/rxr-lbd heterodimer bound to hnc180 and 9cra and src1 |
|
0
|
8
|
6a60B |
Crystal structure of human fxr/rxr-lbd heterodimer bound to gw4064 and 9cra and src1 |
|
67
|
228
|
6a60A |
Crystal structure of human fxr/rxr-lbd heterodimer bound to gw4064 and 9cra and src1 |
|
2
|
11
|
5yxbB |
A ligand binding to fxr |
|
84
|
229
|
5yxdA |
A ligand f binding to fxr |
|
93
|
227
|
5y44A |
A novel moderator xd4 for bile acid receptor |
|
91
|
228
|
5yxjA |
Fxr ligand binding domain |
|
2
|
11
|
5y44B |
A novel moderator xd4 for bile acid receptor |
|
90
|
226
|
5yxlA |
A ligand m binding to fxr |
|
3
|
11
|
5yxjC |
Fxr ligand binding domain |
|
95
|
227
|
5y49A |
A moderator xd22 binding to bile acid receptor |
|
83
|
228
|
5yxbA |
A ligand binding to fxr |
|
2
|
11
|
5yxdB |
A ligand f binding to fxr |
|
3
|
11
|
5y49D |
A moderator xd22 binding to bile acid receptor |
|
1
|
7
|
5yxlB |
A ligand m binding to fxr |
|
2
|
13
|
6hl1B |
Crystal structure of farnesoid x receptor (fxr) with bound ncoa-2 peptide and cdca |
|
92
|
231
|
6hl1A |
Crystal structure of farnesoid x receptor (fxr) with bound ncoa-2 peptide and cdca |
|
3
|
13
|
6hl0B |
Crystal structure of farnesoid x receptor (fxr) with bound ncoa-2 peptide |
|
100
|
231
|
6hl0A |
Crystal structure of farnesoid x receptor (fxr) with bound ncoa-2 peptide |
|
2
|
10
|
6a5yB |
Crystal structure of human fxr/rxr-lbd heterodimer bound to hnc143 and 9cra and src1 |
|
93
|
228
|
6a5yA |
Crystal structure of human fxr/rxr-lbd heterodimer bound to hnc143 and 9cra and src1 |
|
87
|
229
|
6a5xA |
Fxr-lbd with hnc180 and src1 |
|
2
|
12
|
6a5wB |
Fxr-lbd with hnc143 and src1 |
|
3
|
13
|
5q0vB |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q0lB |
Ligand binding to farnesoid-x-receptor |
|
86
|
229
|
5q1hA |
Ligand binding to farnesoid-x-receptor |
|
2
|
10
|
5q10B |
Ligand binding to farnesoid-x-receptor |
|
85
|
229
|
5q17A |
Ligand binding to farnesoid-x-receptor |
|
91
|
228
|
5q0rA |
Ligand binding to farnesoid-x-receptor |
|
2
|
11
|
5q0sB |
Ligand binding to farnesoid-x-receptor |
|
2
|
11
|
5q19B |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q14B |
Ligand binding to farnesoid-x-receptor |
|
88
|
230
|
5q0oA |
Ligand binding to farnesoid-x-receptor |
|
81
|
229
|
5q0tA |
Ligand binding to farnesoid-x-receptor |
|
87
|
230
|
5q16A |
Ligand binding to farnesoid-x-receptor |
|
85
|
229
|
5q0nA |
Ligand binding to farnesoid-x-receptor |
